Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Atomoxetine effects in humans.

Trial Profile

Atomoxetine effects in humans.

Phase of Trial: Phase I/II

Latest Information Update: 09 Dec 2011

At a glance

  • Drugs Atomoxetine (Primary)
  • Indications Attention-deficit hyperactivity disorder
  • Focus Pharmacodynamics
  • Most Recent Events

    • 10 Sep 2009 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
    • 10 Sep 2009 Actual patient number (10) added as reported by ClinicalTrials.gov.
    • 10 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top